GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2018 (FY18) budget.
GHTC endorsed a letter from the CDC Coalition urging House and Senate appropriators to provide robust funding for the US Centers for Disease Control and Prevention (CDC) in the fiscal year 2018 budget.
GHTC submitted a letter to the World Health Organization’s (WHO) Committee on the Selection and Use of Essential Medicines calling for it to approve the proposal to create an essential diagnostics list to complement the essential medicines list (EML). The letter, signed by 12 GHTC members, notes the impact that the EML has had on improving access to medicines and details the ways in which a diagnostics list would have similar impact.
GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board welcoming progress by WHO in operationalizing a Global Observatory on Health Research and Development as a follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG). The statement, which was issued in partnership with the Global Health Council, also encouraged member states to fully fund the observatory and recommended diverse global health stakeholders be consulted as the process moves forward.